LIFE ENHANCEMENT THERAPY

Agin Industries Llc

Application Filed: 2019-03-25
Trademark Application Details
Trademark Logo LIFE ENHANCEMENT THERAPY

Mark For: LIFE ENHANCEMENT THERAPY™ trademark registration is intended to cover the categories of medical clinic providing intravenous infusion therapy; Ketamine infusion therapy for the treatment of severe depression, post traumatic stress disorder, and chronic pain. [all]

Status

2020-07-06 UTC
DEAD UNKNOWN


Research OneLook Acronym Finder
Serial Number88355250
Mark Literal ElementsLIFE ENHANCEMENT THERAPY
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeSERVICE MARK
RegisterPRINCIPAL
Current LocationTMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED 2019-06-11
Basis1(a)
Class StatusACTIVE
Primary US Classes
  • 100: Miscellaneous
  • 101: Advertising and Business
Primary International Class
  • 044 - Primary Class
  • (Medical, beauty & agricultural) Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
Filed UseYes
Current UseYes
Intent To UseNo
Filed ITUNo
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameRaj Abhyanker
Law Office AssignedL30
Employee NameCHISOLM, KEVON

Timeline

2010-12-31Date of First Use
2010-12-31Date of Use In Commerce
2019-03-25Application Filed
2019-06-11Location: TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED
2019-08-31Abandon
2019-09-02Status: Abandoned because the applicant filed an express abandonment. To view all documents in this file, click on the Trademark Documen
2019-09-02Status: Dead/Abandoned
2019-09-03Transaction Date

Trademark Parties (Applicants & Owners)

Party: AGIN INDUSTRIES LLC
AddressC/O LegalForce RAPC Worldwide 446 E Southern Ave Tempe, ARIZONA UNITED STATES 85282
Legal Entity TypeLimited Liability Company
Legal Entity StateFLORIDA

Documents

Attorney of Record

Raj Abhyanker
LegalForce RAPC Worldwide, P.C.
446 E Southern Ave
Tempe AZ 85282

Good, Services, and Codes

(ABANDONED)
IC 044. US 100 101. G & S: Medical clinic providing intravenous infusion therapy; Ketamine infusion therapy for the treatment of severe depression, post traumatic stress disorder, and chronic pain. FIRST USE: 20101231. FIRST USE IN COMMERCE: 20101231

International Codes:44
U.S. Codes:100,101
Type CodeType
GS0441Medical clinic providing intravenous infusion therapy; Ketamine infusion therapy for the treatment of severe depression, post traumatic stress disorder, and chronic pain

Trademark Filing History

DescriptionDateProceeding Number
ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT2019-09-03
ABANDONMENT - EXPRESS MAILED2019-09-02
TEAS EXPRESS ABANDONMENT RECEIVED2019-08-31
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2019-08-06
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2019-08-06
NOTIFICATION OF NON-FINAL ACTION E-MAILED2019-06-116325
NON-FINAL ACTION WRITTEN2019-06-1176502
NON-FINAL ACTION E-MAILED2019-06-116325
ASSIGNED TO EXAMINER2019-06-0476502
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-04-11
NEW APPLICATION ENTERED IN TRAM2019-03-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed